Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Resolution of post-polycythaemic myelofibrosis with a combination of thalidomide and interferon.

Journal of clinical pathology - 1 Aug 2012

Hebballi Sangam, Akiki Susanna, Bareford David

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Marrow Examination
Share to Immunologic Factors
Share to Interferon-alpha
Share to Janus Kinase 2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Polycythemia Vera

Share to Polyethylene Glycols

Share to Primary Myelofibrosis

Share to Thalidomide

Source

Identifiers

PMID: 22412053
DOI: 10.1136/jclinpath-2011-200598

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Resolution of post-polycythaemic myelofibrosis with a combination of thalidomide and interferon.PMID 22412053Read ↗

Relapse of postpolycythemia myelofibrosis after allogeneic stem cell transplantation in a polycythemic phase: successful treatment with donor lymphocyte infusion directed by quantitative PCR test for V617F-JAK2 mutation.Semantic proximity Read ↗

Complete molecular remission in a polycythaemia vera patient 12 years after discontinuation of interferon-alpha.Semantic proximity Read ↗

Pegylated interferon Alfa-2a and hydroxyurea in polycythemia vera and essential thrombocythemia: differential cellular and molecular responses.Semantic proximity Read ↗

Complete remission in a patient with JAK2- and IDH2-positive myelofibrosis.Semantic proximity Read ↗

Tumour lysis syndrome after splenic irradiation in a patient with JAK2 V617F post-polycythaemia vera myelofibrosis.Semantic proximity Read ↗

Recombinant interferon-α in myelofibrosis reduces bone marrow fibrosis, improves its morphology and is associated with clinical response.Semantic proximity Read ↗

Eradication of JAK2 V617F mutation after allogeneic transplantation in a patient with myelofibrosis with myeloid metaplasia.Semantic proximity Read ↗

Resolution of thrombocytopenia, but not polycythemia after ruxolitinib for polycythemia vera with detectable mutation in the exon 12 of the JAK2 gene.Semantic proximity Read ↗

[Interferon-alpha-2b induces molecular responses of patients with polycythemia vera and its post-polycythemic myelofibrosis].Semantic proximity Read ↗

Minimal residual disease and normalization of the bone marrow after long-term treatment with alpha-interferon2b in polycythemia vera. A report on molecular response patterns in seven patients in sustained complete hematological remission.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.